If phishing awareness is buried in HR onboarding, you already have exposure.
Executives must require:
- Quarterly board-level phishing risk reports
- Measured click-rate tracking across departments
- Simulated phishing campaigns with executive participation
- Incident response tabletop exercises tied to real scenarios
If the CEO and CFO aren’t participating in simulations, the culture is signaling that security is optional. That is a mistake.
Phishing campaigns frequently impersonate:
- CRO partners
- Regulatory bodies
- Internal finance requests
- Lab equipment vendors
Small IT teams often lack advanced email inspection, sandboxing, and anomaly detection.
Executives should ensure:
- Advanced threat detection on inbound communications
- SMS filtering policies for corporate mobile devices
- Strict wire transfer verification procedures
- Mandatory multi-factor authentication (MFA) across all accounts
Business email compromise has cost biotech firms millions in fraudulent wire transfers. CFOs must assume they are a target.
- Protect Credentials Like Trade Secrets
Credential harvesting remains the primary objective of phishing.
If attackers gain access to:
- Cloud research repositories
- EHR systems
- Financial platforms
- FDA documentation portals
The exposure goes beyond IT. It becomes regulatory. Under HIPAA and FDA 21 CFR Part 11, unauthorized access and audit trail manipulation are serious violations.
Executives should mandate:
- MFA across all cloud systems
- Conditional access policies
- Privilege access management
- Automated lockout for suspicious login behavior
Credentials are keys to enterprise value. Treat them accordingly.
- Create a “No-Fear” Reporting Culture
Most employees don’t report suspicious emails.
Why?
Embarrassment, shame…the biotech industry is filled with brilliant people, they are going to feel ashamed.
In biotech, silence can cost millions.
CEOs must communicate:
- Reporting a mistake is protected
- Fast reporting reduces impact
- There is no penalty for near-misses
Incident containment speed directly influences:
- Breach size
- Regulatory reporting thresholds
- Business continuity
Time is leverage.
- Align Human Risk with Incident Response Planning
You cannot stop every phishing attempt.
But you can limit blast radius.
Executive leadership should ensure:
- A documented Incident Response Plan
- Defined regulatory reporting workflow
- Pre-established forensic investigation partners
- Business continuity playbooks
If ransomware deploys from a phishing email, how long can lab operations remain offline before trial integrity is compromised?
If the answer is “we’re not sure,” that’s exposure.
The Executive Reality
Phishing is not about email.
It’s about:
- IP theft
- Delayed FDA submissions
- Insurance premiums
- Investor scrutiny
- Reputational damage
And small IT teams cannot monitor threats 24/7. That’s not criticism. That’s capacity reality. Building in-house is also not cost effective.
Biotech firms that treat phishing as operational noise eventually face enterprise consequences.
The question isn’t “Will employees receive phishing attempts?” They already are.
The question is whether leadership has elevated the threat to the appropriate governance level. If your organization has not conducted a formal phishing exposure assessment or executive-level incident simulation, now is the time.
Schedule a risk briefing. Not to buy services. To understand your exposure before someone else does.
About Single Point of Contact
Single Point of Contact is an experienced MSP in the biotech industry and is a valuable partner, providing specialized knowledge in implementing robust backup strategies and ensuring network security and stability. With deep understanding of regulatory requirements such as HIPAA and FDA’s 21 CFR Part 11, Single Point of Contact safeguards sensitive research data, clinical trial information, and intellectual property. They offer tailored solutions, including automated backups, real-time monitoring, and disaster recovery plans, minimizing downtime and data loss. By managing security protocols, they protect against cyber threats, allowing biotech companies to focus on innovation while ensuring compliance and uninterrupted operations. This expertise enhances productivity and reduces risk. Contact us today to discover more about how we can help your biotech firm with DR, backup and security.
